Related Experiment Video

Updated: Aug 15, 2026

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
06:38

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy

Published on: February 7, 2019

Small-molecule antagonists of p53-MDM2 binding: research tools and potential therapeutics

Lyubomir T Vassilev1

  • 1Roche Research Center, Hoffman-La Roche Inc., Nutley, New Jersey 07110, USA. hyubomir.vassilev@roche.com

Cell Cycle (Georgetown, Tex.)
|March 9, 2004
PubMed

Insights

MDM2 antagonists, like Nutlins, activate the tumor-suppressing p53 pathway. These compounds show promise for cancer therapy by inducing cancer cell death while sparing normal cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • The p53 protein is crucial for protecting normal tissues from tumor development by regulating stress responses.
  • MDM2 inhibits p53's tumor-suppressive functions by binding to it, negatively impacting its activity and stability.
  • Targeting the MDM2-p53 interaction presents a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To identify and characterize novel inhibitors of the MDM2-p53 interaction.
  • To evaluate the therapeutic potential of these inhibitors in preclinical cancer models.

Main Methods:

  • Identification of low molecular weight inhibitors targeting MDM2-p53 binding.
  • In vitro and in vivo studies to assess pathway activation and tumor growth suppression.
  • Evaluation of cellular effects on human cancer cells and normal proliferating cells.

Main Results:

  • Discovery of Nutlins, the first potent and selective low molecular weight inhibitors of MDM2-p53 binding.
  • Nutlins activate the p53 pathway, leading to p53-dependent apoptosis in human cancer cells.
  • Nutlins demonstrated cytostatic effects on normal proliferating cells and suppressed osteosarcoma xenografts in vivo.

Conclusions:

  • Nutlins are valuable tools for studying the p53 pathway and its role in cancer.
  • MDM2 antagonists like Nutlins show significant potential for clinical application in treating wild-type p53 tumors.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...